Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients
- 6 January 2017
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 52 (8) , 955-964
Abstract
The effect of maintenance steroid treatment (MST) in reducing the risk of relapse in patients with autoimmune pancreatitis (AIP) remains under debate. The aim of this study was to validate the effect of MST on AIP administered in accordance with the 2010 Japanese consensus guidelines.Keywords
This publication has 22 references indexed in Scilit:
- Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysisGut, 2012
- British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitisGut, 2011
- Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroidsJournal of Gastroenterology, 2011
- Diagnosis and Management of Autoimmune HepatitisHepatology, 2010
- Standard steroid treatment for autoimmune pancreatitisGut, 2009
- Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to TherapyGastroenterology, 2008
- Rituximab Therapy for Refractory Biliary Strictures in Immunoglobulin G4–Associated CholangitisClinical Gastroenterology and Hepatology, 2008
- High Serum IgG4 Concentrations in Patients with Sclerosing PancreatitisNew England Journal of Medicine, 2001
- Use of Oral Corticosteroids and Risk of FracturesJournal of Bone and Mineral Research, 2000
- Chronic pancreatitis caused by an autoimmune abnormalityDigestive Diseases and Sciences, 1995